tiprankstipranks
Trending News
More News >

BioAffinity Technologies gets China patent for siRNA-based cancer therapy

BioAffinity Technologies (BIAF) announced that the China National Intellectual Property Administration has issued a notification of patent grant for the company’s novel composition and method for selectively killing cancer by targeting the CD320 and LRP2 receptors. The newly allowed Chinese patent, titled “Compositions and Methods for Treating Cancer,” covers siRNAs and their use in cancer treatment, similar to its recent U.S. patent. The company is exploring topical application for skin cancers.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1